Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
The Korean Journal of Hepatology
>
2009
>
15
Volume:
15
1. The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease.
Page:59—69
2. Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients.
Page:52—58
3. The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease.
Page:42—51
4. Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea.
Page:25—41
5. Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection.
Page:7—14
6. Inhibition of hepatitis B virus replication by RNA interference.
Page:1—6
7. Current status of liver disease in Korea: Nonalcoholic fatty liver disease.
Page:S34—S39
8. Clevudine therapy in patients with chronic hepatitis B.
Page:119—121
9. Pathology of nonalcoholic steatohepatitis.
Page:122—130
10. Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation.
Page:131—139
11. Distribution of hepatitis B virus genotypes in Korea.
Page:140—147
12. Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma.
Page:148—158
13. Clinical features of hepatic tuberculosis in biopsy-proven cases.
Page:159—167
14. Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B.
Page:168—178
15. Long-term clevudine therapy in nucleos(t)ide-naive and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases.
Page:179—192
16. A case of hypervascular hyperplastic nodules mimicking hepatocellular carcinoma in alcoholic liver cirrhosis.
Page:193—200
17. A case of liver metastasis of gastric hepatoid adenocarcinoma.
Page:201—208
18. A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy.
Page:90—95
19. Current status of liver diseases in Korea: Toxic and alcoholic liver diseases.
Page:S29—S33
20. Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis.
Page:350—356
21. A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization.
Page:357—361
22. Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx.
Page:15—24
23. Current status of liver diseases in Korea: Liver cirrhosis.
Page:S40—S49
24. Current status of liver diseases in Korea: Hepatocellular carcinoma.
Page:S50—S59
25. Current status of liver diseases in Korea: Hepatocellular carcinoma.
Page:S50—S59
26. Current status of hepatic surgery in Korea.
Page:S60—S64
27. Current status of hepatic surgery in Korea.
Page:S60—S64
28. Current status of liver diseases in Korea: Liver cirrhosis.
Page:S40—S49
29. Current status of liver disease in Korea: Nonalcoholic fatty liver disease.
Page:S34—S39
30. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
Page:209—215
31. Primary angiosarcoma of the liver.
Page:216—221
32. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Page:106—110
33. Angiosarcoma.
Page:101—105
34. Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue.
Page:96—100
35. A case of rhabdomyolysis during hospitalization for acute hepatitis A.
Page:85—89
36. A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma.
Page:80—84
37. Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C.
Page:70—79
38. Current status of liver disease in Korea: Hepatitis C.
Page:S25—S28
39. Current status of liver diseases in Korea: Hepatitis B.
Page:S13—S24
40. Current status of liver diseases in Korea: Hepatitis A.
Page:S7—S12
41. Role of cadherin-17 in hepatocellular carcinoma.
Page:533—535
42. Neuroendocrine tumors of the liver.
Page:528—532
43. Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection.
Page:524—527
44. A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.
Page:517—523
45. A case of primary hepatic epithelioid hemangioendothelioma with spontaneous rupture.
Page:510—516
46. Two cases of toxic hepatitis caused by arrowroot juice.
Page:504—509
47. A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C.
Page:496—503
48. Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB.
Page:486—495
49. Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm.
Page:474—485
50. Factors associated with liver stiffness in chronic liver disease.
Page:464—473
51. Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease.
Page:454—463
52. Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients.
Page:446—453
53. Epidemiology and clinical features of acute hepatitis A: from the domestic perspective.
Page:438—445
54. Transient elastography, true or false?.
Page:431—437
55. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma.
Page:227—230
56. Epithelioid hemangioendothelioma.
Page:222—226
57. Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Page:320—330
58. Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease.
Page:309—319
59. Molecular targeting for treatment of advanced hepatocellular carcinoma.
Page:299—308
60. Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease.
Page:295—298
61. Corrections: Distribution of hepatitis B virus genotypes in Korea.
Page:424—424
62. Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients.
Page:383—390
63. Peliosis hepatis.
Page:379—382
64. Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis.
Page:375—378
65. A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C.
Page:370—374
66. Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation.
Page:362—369
67. Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.
Page:338—349
68. Efficacy of 48-week clevudine therapy for chronic hepatitis B.
Page:331—337